Hotline: +86-18022463983    020-85206863

Pharmaceutical & Biotechnology Environmental Monitoring- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: 2025-08-22   |   Pages: 101   |   Tables: 119   |  Medical Care

The global market for Pharmaceutical & Biotechnology Environmental Monitoring was estimated to be worth US$ 1054 million in 2024 and is forecast to a readjusted size of US$ 1565 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Environmental monitoring during pharmaceutical and biopharmaceutical production is crucial for ensuring the safety of formulated drug products. While requirements for the control of both viable (living microorganisms) and non-viable particles (e.g. dust, hair, etc.) and other contaminants (i.e. trace metals, volatiles, etc.) for aseptic manufacturing operations are more extensive than those for non-sterile processes, the quantity of samples that must be analyzed and the amount of data generated can be daunting regardless of the final drug form, particularly for global companies with multiple production facilities.

This report studies the Pharmaceutical & Biotechnology Environmental Monitoring market. It covered Monitoring Equipment, Media, Reagents & Kits, Microbiology Services, Environmental Monitoring and Software used in Pharmaceutical & Biotechnology Environmental Monitoring.
Danaher Corporation, Thermo Fisher Scientific, Merck KGAA, Eurofins Sinensis and Lonza are the leading productors of Pharmaceutical & Biotechnology Environmental Monitoring. The top three accounted for about 20% of the total market.
North America is the largest market, accounting for about 40%. Europe is next with about 25%.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical & Biotechnology Environmental Monitoring, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical & Biotechnology Environmental Monitoring by region & country, by Type, and by Application.
The Pharmaceutical & Biotechnology Environmental Monitoring market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical & Biotechnology Environmental Monitoring.
Market Segmentation
By Company
Danaher Corporation
Thermo Fisher Scientific
Merck KGaA
Eurofins Sinensis
Lonza
Biomerieux
VAI
Cosasco
RMONI
Amphenol Advanced Sensors
Vaisala
Segment by Type
Monitoring Equipment
Media
Software
Microbiology Services
Segment by Application
Pharmaceutical Industry
Biotechnology Industry
Academic & Research Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical & Biotechnology Environmental Monitoring company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pharmaceutical & Biotechnology Environmental Monitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pharmaceutical & Biotechnology Environmental Monitoring in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Market Overview
1.1 Pharmaceutical & Biotechnology Environmental Monitoring Product Introduction
1.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Market Size Forecast (2020-2031)
1.3 Pharmaceutical & Biotechnology Environmental Monitoring Market Trends & Drivers
1.3.1 Pharmaceutical & Biotechnology Environmental Monitoring Industry Trends
1.3.2 Pharmaceutical & Biotechnology Environmental Monitoring Market Drivers & Opportunity
1.3.3 Pharmaceutical & Biotechnology Environmental Monitoring Market Challenges
1.3.4 Pharmaceutical & Biotechnology Environmental Monitoring Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Players Revenue Ranking (2024)
2.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Company (2020-2025)
2.3 Key Companies Pharmaceutical & Biotechnology Environmental Monitoring Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pharmaceutical & Biotechnology Environmental Monitoring Product Offered
2.5 Key Companies Time to Begin Mass Production of Pharmaceutical & Biotechnology Environmental Monitoring
2.6 Pharmaceutical & Biotechnology Environmental Monitoring Market Competitive Analysis
2.6.1 Pharmaceutical & Biotechnology Environmental Monitoring Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical & Biotechnology Environmental Monitoring Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical & Biotechnology Environmental Monitoring as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Monitoring Equipment
3.1.2 Media
3.1.3 Software
3.1.4 Microbiology Services
3.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type
3.2.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, by Type (2020-2031)
3.2.3 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Industry
4.1.2 Biotechnology Industry
4.1.3 Academic & Research Institutes
4.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application
4.2.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, by Application (2020-2031)
4.2.3 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region
5.1.1 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (2020-2025)
5.1.3 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (2026-2031)
5.1.4 Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
5.2.2 North America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
5.3.2 Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
5.4.2 Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
5.5.2 South America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
5.6.2 Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
6.3 United States
6.3.1 United States Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
6.3.2 United States Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
6.4.2 Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
6.5.2 China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
6.5.3 China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
6.6.2 Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
6.7.2 South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
6.8.2 Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020-2031
6.9.2 India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
6.9.3 India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Danaher Corporation
7.1.1 Danaher Corporation Profile
7.1.2 Danaher Corporation Main Business
7.1.3 Danaher Corporation Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
7.1.4 Danaher Corporation Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) & (2020-2025)
7.1.5 Danaher Corporation Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) & (2020-2025)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Profile
7.3.2 Merck KGaA Main Business
7.3.3 Merck KGaA Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
7.3.4 Merck KGaA Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) & (2020-2025)
7.3.5 Merck KGaA Recent Developments
7.4 Eurofins Sinensis
7.4.1 Eurofins Sinensis Profile
7.4.2 Eurofins Sinensis Main Business
7.4.3 Eurofins Sinensis Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
7.4.4 Eurofins Sinensis Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) & (2020-2025)
7.4.5 Eurofins Sinensis Recent Developments
7.5 Lonza
7.5.1 Lonza Profile
7.5.2 Lonza Main Business
7.5.3 Lonza Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
7.5.4 Lonza Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) & (2020-2025)
7.5.5 Lonza Recent Developments
7.6 Biomerieux
7.6.1 Biomerieux Profile
7.6.2 Biomerieux Main Business
7.6.3 Biomerieux Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
7.6.4 Biomerieux Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) & (2020-2025)
7.6.5 Biomerieux Recent Developments
7.7 VAI
7.7.1 VAI Profile
7.7.2 VAI Main Business
7.7.3 VAI Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
7.7.4 VAI Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) & (2020-2025)
7.7.5 VAI Recent Developments
7.8 Cosasco
7.8.1 Cosasco Profile
7.8.2 Cosasco Main Business
7.8.3 Cosasco Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
7.8.4 Cosasco Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) & (2020-2025)
7.8.5 Cosasco Recent Developments
7.9 RMONI
7.9.1 RMONI Profile
7.9.2 RMONI Main Business
7.9.3 RMONI Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
7.9.4 RMONI Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) & (2020-2025)
7.9.5 RMONI Recent Developments
7.10 Amphenol Advanced Sensors
7.10.1 Amphenol Advanced Sensors Profile
7.10.2 Amphenol Advanced Sensors Main Business
7.10.3 Amphenol Advanced Sensors Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
7.10.4 Amphenol Advanced Sensors Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) & (2020-2025)
7.10.5 Amphenol Advanced Sensors Recent Developments
7.11 Vaisala
7.11.1 Vaisala Profile
7.11.2 Vaisala Main Business
7.11.3 Vaisala Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
7.11.4 Vaisala Pharmaceutical & Biotechnology Environmental Monitoring Revenue (US$ Million) & (2020-2025)
7.11.5 Vaisala Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical & Biotechnology Environmental Monitoring Industrial Chain
8.2 Pharmaceutical & Biotechnology Environmental Monitoring Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical & Biotechnology Environmental Monitoring Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical & Biotechnology Environmental Monitoring Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Pharmaceutical & Biotechnology Environmental Monitoring Market Trends
Table 2. Pharmaceutical & Biotechnology Environmental Monitoring Market Drivers & Opportunity
Table 3. Pharmaceutical & Biotechnology Environmental Monitoring Market Challenges
Table 4. Pharmaceutical & Biotechnology Environmental Monitoring Market Restraints
Table 5. Global Pharmaceutical & Biotechnology Environmental Monitoring Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Pharmaceutical & Biotechnology Environmental Monitoring Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Pharmaceutical & Biotechnology Environmental Monitoring Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Pharmaceutical & Biotechnology Environmental Monitoring Product Type
Table 9. Key Companies Time to Begin Mass Production of Pharmaceutical & Biotechnology Environmental Monitoring
Table 10. Global Pharmaceutical & Biotechnology Environmental Monitoring Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical & Biotechnology Environmental Monitoring as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Market Share in Value by Type (2020-2025)
Table 17. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Market Share in Value by Type (2026-2031)
Table 18. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Market Share in Value by Application (2020-2025)
Table 22. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Market Share in Value by Application (2026-2031)
Table 23. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (2020-2025) & (%)
Table 27. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2026-2031) & (US$ Million)
Table 31. Danaher Corporation Basic Information List
Table 32. Danaher Corporation Description and Business Overview
Table 33. Danaher Corporation Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
Table 34. Revenue (US$ Million) in Pharmaceutical & Biotechnology Environmental Monitoring Business of Danaher Corporation (2020-2025)
Table 35. Danaher Corporation Recent Developments
Table 36. Thermo Fisher Scientific Basic Information List
Table 37. Thermo Fisher Scientific Description and Business Overview
Table 38. Thermo Fisher Scientific Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
Table 39. Revenue (US$ Million) in Pharmaceutical & Biotechnology Environmental Monitoring Business of Thermo Fisher Scientific (2020-2025)
Table 40. Thermo Fisher Scientific Recent Developments
Table 41. Merck KGaA Basic Information List
Table 42. Merck KGaA Description and Business Overview
Table 43. Merck KGaA Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
Table 44. Revenue (US$ Million) in Pharmaceutical & Biotechnology Environmental Monitoring Business of Merck KGaA (2020-2025)
Table 45. Merck KGaA Recent Developments
Table 46. Eurofins Sinensis Basic Information List
Table 47. Eurofins Sinensis Description and Business Overview
Table 48. Eurofins Sinensis Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
Table 49. Revenue (US$ Million) in Pharmaceutical & Biotechnology Environmental Monitoring Business of Eurofins Sinensis (2020-2025)
Table 50. Eurofins Sinensis Recent Developments
Table 51. Lonza Basic Information List
Table 52. Lonza Description and Business Overview
Table 53. Lonza Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
Table 54. Revenue (US$ Million) in Pharmaceutical & Biotechnology Environmental Monitoring Business of Lonza (2020-2025)
Table 55. Lonza Recent Developments
Table 56. Biomerieux Basic Information List
Table 57. Biomerieux Description and Business Overview
Table 58. Biomerieux Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
Table 59. Revenue (US$ Million) in Pharmaceutical & Biotechnology Environmental Monitoring Business of Biomerieux (2020-2025)
Table 60. Biomerieux Recent Developments
Table 61. VAI Basic Information List
Table 62. VAI Description and Business Overview
Table 63. VAI Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
Table 64. Revenue (US$ Million) in Pharmaceutical & Biotechnology Environmental Monitoring Business of VAI (2020-2025)
Table 65. VAI Recent Developments
Table 66. Cosasco Basic Information List
Table 67. Cosasco Description and Business Overview
Table 68. Cosasco Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
Table 69. Revenue (US$ Million) in Pharmaceutical & Biotechnology Environmental Monitoring Business of Cosasco (2020-2025)
Table 70. Cosasco Recent Developments
Table 71. RMONI Basic Information List
Table 72. RMONI Description and Business Overview
Table 73. RMONI Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
Table 74. Revenue (US$ Million) in Pharmaceutical & Biotechnology Environmental Monitoring Business of RMONI (2020-2025)
Table 75. RMONI Recent Developments
Table 76. Amphenol Advanced Sensors Basic Information List
Table 77. Amphenol Advanced Sensors Description and Business Overview
Table 78. Amphenol Advanced Sensors Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
Table 79. Revenue (US$ Million) in Pharmaceutical & Biotechnology Environmental Monitoring Business of Amphenol Advanced Sensors (2020-2025)
Table 80. Amphenol Advanced Sensors Recent Developments
Table 81. Vaisala Basic Information List
Table 82. Vaisala Description and Business Overview
Table 83. Vaisala Pharmaceutical & Biotechnology Environmental Monitoring Products, Services and Solutions
Table 84. Revenue (US$ Million) in Pharmaceutical & Biotechnology Environmental Monitoring Business of Vaisala (2020-2025)
Table 85. Vaisala Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Pharmaceutical & Biotechnology Environmental Monitoring Downstream Customers
Table 89. Pharmaceutical & Biotechnology Environmental Monitoring Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts


List of Figures
Figure 1. Pharmaceutical & Biotechnology Environmental Monitoring Product Picture
Figure 2. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2020-2031) & (US$ Million)
Figure 4. Pharmaceutical & Biotechnology Environmental Monitoring Report Years Considered
Figure 5. Global Pharmaceutical & Biotechnology Environmental Monitoring Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Pharmaceutical & Biotechnology Environmental Monitoring Revenue in 2024
Figure 7. Pharmaceutical & Biotechnology Environmental Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Monitoring Equipment Picture
Figure 9. Media Picture
Figure 10. Software Picture
Figure 11. Microbiology Services Picture
Figure 12. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 13. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Market Share by Type, 2024 & 2031
Figure 14. Product Picture of Pharmaceutical Industry
Figure 15. Product Picture of Biotechnology Industry
Figure 16. Product Picture of Academic & Research Institutes
Figure 17. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 18. Global Pharmaceutical & Biotechnology Environmental Monitoring Sales Value Market Share by Application, 2024 & 2031
Figure 19. North America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (2020-2031) & (US$ Million)
Figure 20. North America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (%), 2024 VS 2031
Figure 21. Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2031) & (US$ Million)
Figure 22. Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (%), 2024 VS 2031
Figure 23. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2031) & (US$ Million)
Figure 24. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Region (%), 2024 VS 2031
Figure 25. South America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2031) & (US$ Million)
Figure 26. South America Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (%), 2024 VS 2031
Figure 27. Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2031) & (US$ Million)
Figure 28. Middle East & Africa Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Country (%), 2024 VS 2031
Figure 29. Key Countries/Regions Pharmaceutical & Biotechnology Environmental Monitoring Sales Value (%), (2020-2031)
Figure 30. United States Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2031) & (US$ Million)
Figure 31. United States Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
Figure 32. United States Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (%), 2024 VS 2031
Figure 33. Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2031) & (US$ Million)
Figure 34. Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
Figure 35. Europe Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (%), 2024 VS 2031
Figure 36. China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2031) & (US$ Million)
Figure 37. China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
Figure 38. China Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (%), 2024 VS 2031
Figure 39. Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2031) & (US$ Million)
Figure 40. Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
Figure 41. Japan Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (%), 2024 VS 2031
Figure 42. South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2031) & (US$ Million)
Figure 43. South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
Figure 44. South Korea Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (%), 2024 VS 2031
Figure 45. Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
Figure 47. Southeast Asia Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (%), 2024 VS 2031
Figure 48. India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value, (2020-2031) & (US$ Million)
Figure 49. India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Type (%), 2024 VS 2031
Figure 50. India Pharmaceutical & Biotechnology Environmental Monitoring Sales Value by Application (%), 2024 VS 2031
Figure 51. Pharmaceutical & Biotechnology Environmental Monitoring Industrial Chain
Figure 52. Pharmaceutical & Biotechnology Environmental Monitoring Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Our Clients